ARC Fertility Logo
ARC Fertility Highlights Importance of Menopause Benefits During October Menopause Awareness Month
October 02, 2024 12:05 ET | ARC Fertility
ARC Fertility Highlights Importance of Menopause Benefits During October Menopause Awareness Month
Premom's Supplement and Fertility Product Line
Premom Launches Female Doctor-Formulated Supplement Line to Revolutionize Women’s Health and Fertility
October 01, 2024 10:30 ET | Easy Healthcare Corporation
Burr Ridge, IL, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Premom, a leader in women’s fertility technology and the driving force behind Amazon’s best-selling ovulation tests, proudly announces the launch of...
22157.jpg
U.S. Advanced Breast Cancer Report: Patient-Reported Data on HCP Treatment Discussions, Treatment Satisfaction & Awareness, Clinical Trial Interest, and Much More
September 26, 2024 04:24 ET | Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Advanced Breast Cancer in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...
22157.jpg
HER2 Positive Breast Cancer Treatment Pipeline Landscape 2024: Insight Report Reveals Over 60 Companies Developing Innovative Therapies
September 25, 2024 04:09 ET | Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "HER2 Positive Breast Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The report encompasses an in-depth...
22157.jpg
Gynecology Collaboration and Licensing Agreements Trends Analysis Report 2024 with a Directory of 148 Deals Signed Since 2016 by Company A-Z, Therapy Focus and Technology Type
September 24, 2024 10:10 ET | Research and Markets
Dublin, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The "Gynecology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Gynecology Collaboration and...
U.S. Women’s Health Market
U.S. Women's Health Market Size, Share & Trends Analysis Report 2024-2030: Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, PCOS
September 20, 2024 04:04 ET | Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Endometriosis & Uterine Fibroids), By Age (50...
U.S. Contraceptive Market
U.S. Contraceptive Market Report 2024-2030: Pills, Intrauterine Devices (IUD), Condoms, Vaginal Ring, Subdermal Implants, Injectables Size, Share & Trends Analysis
September 19, 2024 10:43 ET | Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "U.S. Contraceptive Market Size, Share & Trends Analysis Report By Product (Pills, Intrauterine Devices (IUD), Condoms, Vaginal Ring, Subdermal...
22157.jpg
United States Endometriosis and Uterine Fibroids Markets, 2020-2024 & 2025-2030: Rise in Non-Invasive Drug Therapies Driving Growth, Online Pharmacies Set to Revolutionize Distribution
September 19, 2024 07:25 ET | Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "United States Endometriosis and Uterine Fibroids Market (2024 Edition): Analysis By Drug Type, By Route of Administration, By Distribution Channel, By...
UAE In-Vitro Fertilization (IVF) Market
UAE In-Vitro Fertilization (IVF) Market Research
September 18, 2024 04:20 ET | Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "UAE In-Vitro Fertilization (IVF) Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F" report has been added to ...
22157.jpg
OC/LEP (Oral Contraception, Low Dose Estrogen Progestin) Market Research 2024 Featuring Johnson & Johnson, Sanofi, Novartis, Pfizer, Bayer, Merck, Teva, Abbvie, Viatris, and Cipla
September 12, 2024 09:55 ET | Research and Markets
Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "Global OC/LEP Market (2024 Edition): Analysis by Type (Combination Contraceptives Pills, Progestin-only Pills), By Distribution Channel, By Region, By...